Robert Hershberg

Companies

• AtaiBeckley Inc.Board member Jun 8, 2026 to now¹
• Atai Beckley N.V.Board member Nov 6, 2025 to now²
• HilleVax, Inc.Officer Feb 12, 2024 to now³
• HilleVax, Inc.Board member Apr 28, 2022 to now⁴
• HilleVax, Inc.Chief executive officer Apr 28, 2022 to now⁴
• HilleVax, Inc.President Apr 28, 2022 to now⁴
• Recursion PharmaceuticalsBoard member Apr 15, 2021 to now⁵
• Adaptive BiotechnologiesBoard member Jun 26, 2019 to now⁶
• Fate TherapeuticsBoard member May 5, 2020 to Jun 7, 2023⁷
• Silverback TherapeuticsBoard member Dec 3, 2020 to Jun 13, 2022⁸
• NanoString TechnologiesBoard member Mar 3, 2015 to Apr 18, 2022⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAdaptive Biotechnologies ADPT46,683 shares¹⁰$1.1M at $24.01Aug 18, 2026
• Recursion Pharmaceuticals RXRX162,156 shares¹¹$589.4K at $3.63Jun 17, 2026
• FTFate Therapeutics FATE10,659 shares¹²$20.0K at $1.88Jun 9, 2022
• NanoString Technologies10,716 shares¹³Apr 18, 2022
• HHilleVax, Inc.0 shares¹⁴Sep 17, 2025
• AAtaiBeckley Inc.100,000 shares¹⁵Jul 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 18, 2026Sold 15,664 shares at $24.41 of Adaptive Biotechnologies¹⁰
• Aug 18, 2026Sold 15,000 shares at $24.39 of Adaptive Biotechnologies¹⁰
• Aug 18, 2026Exercised options 15,000 shares at $6.32 of Adaptive Biotechnologies¹⁰
• Jul 7, 2026Sold 100,000 shares at $4.96 of AtaiBeckley Inc.¹⁵
• Jul 7, 2026Exercised options 51,142 shares at $1.35 of AtaiBeckley Inc.¹⁵
• Jul 7, 2026Exercised options 48,858 shares at $1.35 of AtaiBeckley Inc.¹⁵
• Jun 17, 2026Granted 88,424 shares of Recursion Pharmaceuticals¹¹
• Mar 4, 2026Granted 15,625 shares of Adaptive Biotechnologies¹⁶
• Dec 10, 2025Sold 22,968 shares at $16.00 of Adaptive Biotechnologies¹⁷
• Sep 17, 2025U 1,101,498 shares of HilleVax, Inc.¹⁴
• Jun 18, 2025Granted 22,016 shares of Recursion Pharmaceuticals¹⁸
• Mar 12, 2025Sold 53,000 shares at $7.59 of Adaptive Biotechnologies¹⁹
• Mar 4, 2025Granted 15,394 shares of Adaptive Biotechnologies²⁰
• Feb 11, 2025Sold 11,901 shares at $1.76 of HilleVax, Inc.²¹
• Feb 4, 2025Sold 14,634 shares at $1.89 of HilleVax, Inc.²¹
• Jun 3, 2024Granted 13,097 shares of Recursion Pharmaceuticals²²
• Mar 4, 2024Granted 31,328 shares of Adaptive Biotechnologies²³
• Feb 8, 2024Granted 174,202 shares of HilleVax, Inc.²⁴
• Feb 8, 2024Sold 11,597 shares at $14.93 of HilleVax, Inc.²⁴
• Jun 16, 2023Granted 12,612 shares of Recursion Pharmaceuticals²⁵
• Mar 6, 2023Granted 14,775 shares of Adaptive Biotechnologies²⁶
• Feb 2, 2023Exercised options 53,000 shares at $0.45 of Adaptive Biotechnologies²⁷
• Feb 1, 2023Granted 187,966 shares of HilleVax, Inc.²⁸
• Jun 14, 2022Granted 18,145 shares of Recursion Pharmaceuticals²⁹
• Jun 9, 2022Granted 8,650 shares of Fate Therapeutics¹²